CIK 0001326190
- Non-accelerated filer
- Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 202726770
- Phone
- +1 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- 4 Open-market buy Director bought 23,745 shares at an average $1.78 ($42,304)
- 4 Open-market buy Director bought 26,010 shares at an average $1.79 ($46,588)
- 4 Open-market buy Director bought 33,315 shares at an average $1.91 ($63,639)
- 4 Open-market buy Director bought 21,808 shares at an average $2.03 ($44,282)
- 4 Open-market buy Director bought 18,331 shares at an average $2.08 ($38,215)
- 4 Other acquisition 10% owner acquired 40,099 shares (other)
- 4 Other acquisition 10% owner acquired 182,262 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Other disposition Director disposed of 1,278,471 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 67,326 shares at an average $2.25 ($151,282)
- 4 Open-market buy Director bought 10,000 shares at an average $2.21 ($22,097)
- 4 Open-market buy Director bought 50,000 shares at an average $2.21 ($110,263)
Page 17 of 34 · 675 filings